Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 + Cisplatin in Advanced Gastric Cancer
NCT00072787Phase 2Completed
- Sponsor
- Taiho Oncology
- Start
- Oct 2003
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur in gastric cancer (GC), sponsored by Taiho Oncology. Primary endpoints: Safe dose of S-1 and cisplatin and Antitumor activity. Started Oct 2003; status: completed.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00072787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00072787.